Neuromuscular Ultrasonography Assessment of Optic Nerve in Systemic Lupus Eryhematosus
NCT ID: NCT05853003
Last Updated: 2024-07-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
140 participants
OBSERVATIONAL
2022-01-01
2023-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neuromuscular Ultrasonography Utility for Detection of Peripheral Neuropathy in Systemic Lupus Erythematosus
NCT04527172
Ultrasound-Based Detection Of Subclinical Arthritis Among Patients With Systemic Lupus
NCT05844917
Posterior Segment Evaluation of Patients With SLE Using OCT and OCTA
NCT04866615
Systemic Lupus and Adverse Pregnancy Outcome
NCT03171103
AS-OCT Study of Cornea and Tear Film Parameters in SLE Patients
NCT04873739
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* group of SLE patients, who fulfilled Systemic Lupus International Collaborating Clinics classification criteria for SLE (SLICC) with or without symptoms of optic neuropathy
* another group of apparently healthy subjects with no. history of chronic conditions
Exclusion Criteria
* Post traumatic neuropathy
* Purely degenerative neuropathy
* Diabetic neuropathy
* Toxic neuropathy
* Neuropathies related to infections
* Drug induced neuropathy e.g: quinine and some antibiotics, ethambutol
* Infections e.g. measles, mumps, Lyme disease, etc.
* Other Autoimmune diseases like sarcoidosis, B.D
* Tumor causing Inc. intracranial tension.
17 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Amira M elSonbaty
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amira M elSonbaty
Amira Elsonbaty
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amira elsonbaty, PHD
Role: PRINCIPAL_INVESTIGATOR
Assiut University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assuit university hospital
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
bending
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.